Gabapentinoid Pharmacology in the Context of Emerging Misuse Liability

Author:

Evoy Kirk E.12,Peckham Alyssa M.34,Covvey Jordan R.5,Tidgewell Kevin J.5

Affiliation:

1. The University of Texas at Austin College of Pharmacy Austin Texas USA

2. University Health System San Antonio Texas USA

3. School of Pharmacy, Northeastern University Boston Massachusetts USA

4. Department of Pharmacy, Massachusetts General Hospital Boston Massachusetts USA

5. Duquesne University School of Pharmacy Pittsburgh Pennsylvania USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference100 articles.

1. Gabapentin approvals, off‐label use, and lessons for postmarketing evaluation efforts;Wallach JD;JAMA,2018

2. Assessment of Pregabalin Postapproval Trials and the Suggestion of Efficacy for New Indications

3. Drug Enforcement Administration Department of Justice.Schedules of controlled substances: placement of pregabalin into Schedule V. Docket No. DEA‐267F. 21 CFR Part 1308.https://www.deadiversion.usdoj.gov/fed_regs/rules/2005/fr0728.htm. Published 2005. Accessed January 24 2021.

4. Gabapentinoid Use in the United States 2002 Through 2015

5. IQVIA Institute for Human Data Science.Medicine use and spending in the US: a review of 2018 and outlook to 2023.https://www.iqvia.com/‐/media/iqvia/pdfs/institute‐reports/medicine‐use‐and‐spending‐in‐the‐us‐a‐review‐of‐2018‐outlook‐to‐2023.pdf?_=1597332878366. Published 2019. Accessed January 24 2021.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3